PBRC 소속의 연구원인 Nagendra Kaushik 교수가 PLoS One과 Current Pharmaceutical Biotechnology의 Editorial Board
멤버로써 참여하게 되었습니다.
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
Dear Prof. Kaushik,
Thank you again for your joining the Editorial Board of PLOS ONE. I have would be
delighted to offer you a position on the Board.
PLOS ONE launched at the end of December 2006 as an efficient and economical venue for
disseminating research in all areas of science and medicine. Today it is the largest journal in
the world, publishing well over 2000 articles per month. The underlying philosophy is that all
research, if well-performed and well-reported, has something of value to offer the scientific
community, and accordingly, PLOS ONE’s editorial criteria focuses on the technical quality
of the work rather than any subjective judgments such as perceived novelty or limited
relevance to a specialist field.
Editorial Board members at PLOS ONE are given a high degree of editorial autonomy over
the papers that they handle, and are responsible for deciding whether a manuscript adheres
to the journal’s criteria for publication. In general, we are looking for forward-looking
individuals who are enthusiastic about this reinvention of scientific publishing in an Open
Access environment. Initial appointments to the PLOS ONE Editorial Board are for three
years, subject to review on an annual basis.
By joining PLOS ONE as an Academic Editor, you will be supporting the PLOS mission of
freely disseminating rigorous scientific research to the public, worldwide.
I’d be glad to answer any specific questions you may have, and I look forward to receiving
your formal acceptance. In your email, please include a detailed signature, including
accurate and current affiliation and contact information:
I look forward to your reply.
With best regards,
Michelle Dohm
Senior Editor, Editorial Board Services,
PLOS ONE
PLOS I OPEN FOR DISCOVERY
1160 Battery Street, Suite 225, San Francisco, CA 94111
cclarke@plos.org | Main +1 415-624- 1200 | Fax +1 415-546- 4090
plos.org | Facebook | Twitter | Blog
Case Number: 05551862
ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー
15 February 2018
Dr. N.K. Kaushik
Plasma Bioscience Research Center,
Department of Electrical & Biological Physics,
Kwangwoon University
Seoul 139701, South Korea
Dear Dr. Kaushik,
Current Pharmaceutical Biotechnology (Impact Factor 2.459) is currently in its 19th year of
publication. It publishes in-depth reviews, research articles and letters written by leaders in the field
covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical
Biotechnology.
In view of your contributions in the field, we would like to propose your name as an Editorial Board
Member. Editorial Board Members are entitled to a number of benefits mentioned in journal
guidelines.
Best regards,
M. Alam
Director (Publications)
Current Pharmaceutical Biotechnology
__________________________________________________________________________
Dear Dr. Kaushik,
Thank you very much and welcome to our board of CPB. I would like to introduce myself as dealing
manager of CPB. I am Pharmacists and leading this journal along with other journals in my group. We
hope that with your expert association the journal will grow further.
Please feel free to contact me in case of any other query.
Thanks and regards,
Sumaiya Azhar (Ms.)
Manager (Publications)
Current Pharmaceutical Biotechnology
Bentham Science Publishers
Email: cpb@benthamscience.org